Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 12:00 AM
NCT ID:
NCT02106858
Eligibility Criteria:
* Inclusion Criteria:
* Signed and dated informed consent
* Patients diagnosed with histologically confirmed metastatic colorectal cancer and/or metastatic or unresectable locally advanced gastrointestinal stromal tumors and/or HCC who have been previously treated with sorafenib by physician
* Patients who are prescribed with Stivarga tablet 40mg(Regorafenib) for the first time
* Exclusion Criteria:
* Patients participating in an investigational program with interventions outside of routine clinical practice
* All contra-indications according to the local marketing authorization have to be considered.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02106858
Study Brief:
Protocol Section:
NCT02106858